Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMortgage Advice Bureau Regulatory News (MAB1)

Share Price Information for Mortgage Advice Bureau (MAB1)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 862.00
Bid: 860.00
Ask: 870.00
Change: -8.00 (-0.92%)
Spread: 10.00 (1.163%)
Open: 862.00
High: 872.00
Low: 862.00
Prev. Close: 870.00
MAB1 Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

28 Jan 2020 07:00

RNS Number : 0771B
Mortgage Advice Bureau(Holdings)PLC
28 January 2020
 

28 January 2020

Mortgage Advice Bureau (Holdings) plc 

("MAB" or the "Group")

Trading Update 

Mortgage Advice Bureau (Holdings) plc (AIM: MAB1), one of the UK's leading consumer intermediary brands and specialist Appointed Representative networks, today issues a trading update for the year ended 31 December 2019, ahead of publishing its final results on Tuesday, 24 March 2020(1).

Revenue for the year increased by 16% to £143m, with strong organic revenue growth of 10% (11% on an underlying basis(2)) to £135m for the core MAB business driven by a 14% increase in the average number of core MAB Advisers for the year to 1,293 (2018: 1,130). First Mortgage Direct Limited ("First Mortgage"), which was acquired on 2 July 2019, contributed an additional £8m of revenue.

We increased the total number of Advisers at the year end by 20% to 1,457 (2018:1,213), with organic growth in adviser numbers of 13% or 162 to 1,375, supplemented by the 82 Advisers brought into the Group with First Mortgage. 

Activity in the housing market was impacted by the continuing political and economic uncertainties associated with Brexit, particularly in the earlier part of 2019, and we saw a drop in underlying average annual revenue per Adviser for the core MAB business of 3%. However, we have seen improving productivity through H2 2019, relative to H1 2019, and we expect the UK General Election result along with the many focused initiatives that MAB has in place, including process efficiencies and lead generation, supported by our technology developments, to generate growth in revenue per Adviser in 2020, irrespective of the level of activity in the broader market. 

UK Finance(3) estimates that gross new mortgage lending for 2019 was £266bn, a 1% reduction on 2018. The Intermediary Mortgage Lenders Association's current estimates (published post the general election) are £268bn for gross new mortgage lending in 2020 and £275bn in 2021.

The Group's profit before tax for the year ended 31 December 2019 is in line with the Board's expectations. At 31 December 2019, the Group had a strong balance sheet with a cash position of £21m, including £7m of unrestricted cash balances. At the year end the Group had no borrowings drawn down on its revolving credit facility (which was put in place at the time of the First Mortgage acquisition), demonstrating the strong cash generation of MAB's business model.

(1) It is expected that a proposed final dividend in respect of the year ended 31 December 2019 will be paid on 29 May 2020 to shareholders on the register at close of business on 1 May 2020.

(2) Underlying basis excludes a one-off adjustment in H1 2018 of £1.7m for procuration fees awaiting processing

(3) UK Finance estimates for gross new mortgage lending for 2020 and 2021 were published before the general election in December 2019

Peter Brodnicki, CEO of MAB, said:

"MAB has delivered another strong performance despite the prolonged political and economic uncertainties throughout 2019. We continue to deliver on our strategy to grow our market share in all conditions by investing to ensure sustainable growth whilst maintaining a strong financial position. 

"We are capitalising upon our protection and lead generation initiatives to further improve performance and continue to pilot our new technology platform, with rollout to a number of our ARs in the first half of 2020. These initiatives are important recruitment drivers for ARs, Advisers and lead sources."

Market Abuse Regulation (MAR) Disclosure

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No 596/2014. Upon the publication of this announcement, this inside information is now considered to be in the public domain.

Enquiries:

Mortgage Advice Bureau (Holdings) plc +44 (0)1332 525007

Peter Brodnicki, Chief Executive Officer

Ben Thompson, Deputy Chief Executive Officer

Lucy Tilley, Chief Financial Officer

Nominated Adviser and Broker: +44 (0)20 7260 1000

Numis Securities Limited

Stephen Westgate / Hugo Rubinstein (Corporate Finance)

Michael Burke (Corporate Broking)

 

Media Enquiries:

 

investorrelations@mab.org.uk

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
TSTSEWEFWESSEFF
Date   Source Headline
13th Jun 20234:39 pmRNSTR-1: Notification of major holdings
1st Jun 202311:52 amRNSDirector/PDMR Shareholding
24th May 20235:16 pmRNSResult of AGM
24th May 20237:00 amRNSAGM Statement
16th May 20232:23 pmRNSPDMR Dealing and Total Voting Rights
28th Apr 20231:53 pmRNSDirectors' Shareholdings and PDMR notification
27th Apr 20234:39 pmRNSNotification of major holdings
20th Apr 20234:29 pmRNSPosting of Report and Accounts and Notice of AGM
17th Apr 20235:08 pmRNSPDMR dealing and Total Voting Rights
31st Mar 20232:25 pmRNSDirectors' Shareholdings and PDMR notification
28th Mar 20237:00 amRNSFinal Results for the year ended 31 December 2022
14th Mar 20235:05 pmRNSDirectors' Shareholdings and PDMR notification
9th Mar 20234:35 pmRNSPrice Monitoring Extension
9th Mar 20233:35 pmRNSNon-Executive Director Board change
2nd Mar 20234:35 pmRNSPrice Monitoring Extension
28th Feb 20231:54 pmRNSDirectors' Shareholdings and PDMR notification
24th Feb 20234:35 pmRNSPrice Monitoring Extension
14th Feb 20235:06 pmRNSDirectors' Shareholdings and PDMR notification
2nd Feb 20234:35 pmRNSPrice Monitoring Extension
31st Jan 20234:29 pmRNSDirectors' Shareholdings and PDMR notification
31st Jan 20237:00 amRNSTrading Update
17th Jan 20234:07 pmRNSDirectors' Shareholdings and PDMR notification
3rd Jan 20239:54 amRNSDirector's Shareholdings and PDMR notification
21st Dec 20227:00 amRNSAppointment of Joint Broker
14th Dec 20224:40 pmRNSSecond Price Monitoring Extn
14th Dec 20224:35 pmRNSPrice Monitoring Extension
14th Dec 20221:51 pmRNSDirectors' Shareholdings and PDMR notification
1st Dec 20227:00 amRNSTrading Update
30th Nov 20224:50 pmRNSDirectors' Shareholdings and PDMR notification
14th Nov 20224:15 pmRNSPDMR dealing notification and Total Voting Rights
7th Nov 20225:01 pmRNSDirectors' Shareholdings and PDMR notification
31st Oct 20221:18 pmRNSDirectors' Shareholdings and PDMR notification
14th Oct 20225:04 pmRNSDirectors' Shareholdings and PDMR notification
6th Oct 20225:16 pmRNSHolding(s) in Company
6th Oct 20227:00 amRNSDirectors' Shareholdings and PDMR notification
4th Oct 20224:27 pmRNSHolding(s) in Company
3rd Oct 20225:13 pmRNSTotal Voting Rights
3rd Oct 20225:11 pmRNSHolding(s) in Company
30th Sep 202210:21 amRNSDirectors' Shareholdings and PDMR notification
27th Sep 20227:00 amRNSInterim Results
16th Sep 202210:36 amRNSDirectors' Shareholdings and PDMR notification
31st Aug 202212:53 pmRNSDirectors' Shareholdings and PDMR notification
16th Aug 202210:27 amRNSDirector/PDMR Shareholding
8th Aug 20224:36 pmRNSDirectors' Shareholdings and PDMR notification
29th Jul 20221:03 pmRNSPDMR dealing notification and Total Voting Rights
28th Jul 20224:40 pmRNSSecond Price Monitoring Extn
28th Jul 20224:35 pmRNSPrice Monitoring Extension
28th Jul 20227:00 amRNSTrading Update
14th Jul 20225:31 pmRNSDirector/PDMR Shareholding
14th Jul 20224:40 pmRNSSecond Price Monitoring Extn

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.